Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples